The isolation of viruses with mutations in essential genes requires that they be propagated in cells expressing the wild-type proteins. This has been a particularly challenging problem for studying mutations in the human cytomegalovirus (HCMV) immediate early (IE) gene, IE2 86. In the past, we tried a number of approaches to derive human fibroblasts expressing wild-type IE2 86, but were unable to maintain expression of a fully functional protein. To overcome this obstacle, we developed a strategy whereby recombinant baculoviruses were used as vectors for the expression of HCMV IE proteins in primary human fibroblasts (FFs). The IE2 86 and IE1 72 cDNAs, as well as the genomic fragment of the UL122-123 region under the control of a chicken actin promoter, were introduced into the baculovirus genome by site-specific transposition in Escherichia coli. Recombinant "bacmid" DNAs were then transfected into Sf9 cells to generate recombinant baculoviruses. FFs infected at high m.o.i. with these baculoviruses expressed high levels of the HCMV protein for at least 1 week, as determined by immunofluorescence assays and Western blots. Moreover, the IE2 86 protein was found to be fully functional with respect to its ability to activate the HCMV UL112-113 early promoter. Recombinant baculoviruses expressing IE1 72 were also able to efficiently complement HCMV ie1 mutants. These data demonstrate the potential of using recombinant baculoviruses as vectors for the expression of toxic viral genes in human cells and for subsequent isolation of mutant HCMV lacking these essential genes.
INTRODUCTION
Human cytomegalovirus (HCMV), a ␤-herpesvirus, is an opportunistic pathogen that causes disease in newborns and susceptible immunocompromised individuals (Britt and Alford, 1996) . Upon infection, HCMV gene expression occurs in a temporally regulated fashion (for review see Mocarski, 1996) . The expression of immediate early (IE) genes is required for the subsequent expression of early and late genes. Successful replication in the host is initially dependent upon the appearance of the IE nuclear phosphoproteins of 72 kDa (IE1 72; ppUL123) and 86 kDa (IE2 86; ppUL122). The RNA transcripts encoding these proteins originate from the major IE enhancer promoter and are alternatively spliced. The message for IE1 72 comprises exons 1 to 4, whereas the IE2 86 transcript consists of exons 1 to 3 and 5. Translation of both proteins is initiated at exon 2, and they share 85 amino acids (aa) at their amino termini.
The IE1 72 and IE2 86 proteins have been studied in detail with regard to their roles in regulation of viral and cellular gene expression (for review see Fortunato and Spector, 1999; Mocarski, 1996) . IE1 72 is the most abundant product of the IE region. It can autoregulate the HCMV IE promoter via NF-␤ and can associate with several regulatory proteins, including some TBP-associated factors, the transcription factor CTF-1, and the Rbrelated protein p107 (Hayhurst et al., 1995; Lukac et al., 1997; Poma et al., 1996) . Coexpression of IE1 72 augments the regulatory properties of IE2 86, a major transactivator of HCMV and heterologous promoters. IE2 86 can interact with itself and the viral 75 kDa early protein (UL84), as well as with the components of the basal transcription complex (TBP and TFIIB), several TBP-associated factors, and specific transcription factors and products of the tumor suppressor genes p53 and Rb (Caswell et al., 1993; Chiou et al., 1993; Choi et al., 1995; Furnari et al., 1993; Hagemeier et al., 1992; Jupp et al., 1993; Lang et al., 1995; Lukac et al., 1994 Lukac et al., , 1997 Schwartz et al., 1996; Scully et al., 1995; Sommer et al., 1994; Spector and Tevethia, 1994; Speir et al., 1994; Yoo et al., 1996) . IE2 86 can also bind to DNA in a site-specific but sequence-tolerant manner (Arlt et al., 1994; Cherrington et al., 1991; Huang and Stinski, 1995; Liu et al., 1991; Pizzorno and Hayward, 1990; Rodems et al., 1998; Schwartz et al., 1994; Scully et al., 1995) .
The properties of the IE proteins have been characterized thus far primarily using in vitro analyses and in vivo transient expression assays. A more accurate understanding of IE gene function in the context of viral replication, however, requires analysis of mutant viruses. Toward this end, a recombinant virus unable to synthesize IE1 72 was isolated by complementing the deficient protein in an immortalized IE1 72-expressing human fibroblast cell line, ihfie 1.3 (Mocarski et al., 1996, Greaves and Mocarski, 1998) . Several groups have attempted to establish an IE2 86 cell line capable of complementing ie2 mutants without success. One possible explanation is that continuous expression of wild-type IE2 86 is deleterious for the host cell. This suspicion is further strengthened by the finding that the one reported fibroblast cell line that expresses IE2 86 (Bonin and McDougall, 1997 ) is unable to significantly transactivate the HCMV UL112-113 promoter (our unpublished results). Moreover, it has recently been found that the IE2 86 gene in these cells has mutations in a critical region of the protein (Murphy et al., 2000) . In addition, our attempts to generate retroviruses and replication-defective adenoviruses expressing wild-type IE2 86 have been unsuccessful. However, recently Murphy and colleagues have reported success in generating an adenovirus vector expressing functional IE2 86 when the IE2 86 gene is under the control of a Tet-inducible promoter (Murphy et al., 2000) .
The baculovirus (Autographa californica nucleopolyhedrosis virus, AcNPV) expression system has been widely used for the synthesis of high levels of foreign proteins in insect cells (for review see Luckow and Summers, 1988) . The benefit of this system is the production of large quantities of recombinant proteins with the proper posttranslational modifications. Until recently, the ability of baculoviruses to infect mammalian cells was only demonstrated in cells of hepatic origin (Boyce and Bucher, 1996) . The use of promoters from other viruses to drive expression of heterologous proteins was also limited to these cell types. However, the finding that the strong chicken actin promoter coupled with a rabbit ␤-globin poly(A) site (CAG) can drive baculovirus-mediated protein expression in other mammalian cell types (Shoji et al., 1997) has opened the possibility of using this system for expression of HCMV IE proteins in FFs to provide the complementation necessary to isolate HCMV mutants. This system provides sustained expression for several days and the baculoviruses cannot replicate in mammalian cells. Moreover, the heterologous protein is not expressed during propagation of the baculovirus in insect cells and is only expressed for a limited time in FFs. Therefore there is no selection against the wild-type gene if the protein has any detrimental effects on the cell.
The generation of recombinant baculoviruses by traditional methods has several drawbacks, including a low frequency of recombination and the requirement for several rounds of plaque purification. However, the use of site-specific transposon-mediated insertion of foreign genes into a baculoviral genome that is maintained as a self-replicating episome (bacmid) in Escherichia coli (Luckow et al., 1993) has greatly facilitated the rapid generation of recombinant baculoviruses. We have used this alternative strategy to construct baculoviruses that were capable of expressing high levels of HCMV IE proteins in FFs. The recombinant IE2 86 was capable of transactivating the HCMV UL112-113 promoter, thus demonstrating that it is a functional protein. Moreover, the HCMV ie1 mutant CR208 was found to replicate in FFs expressing IE1 72 from the recombinant baculovirus with an efficiency that is comparable to that observed in a complementing fibroblast cell line. Taken together, these data suggest that it may be possible to isolate mutants in essential HCMV genes with baculovirus-mediated transcomplementation.
RESULTS
Efficient construction of recombinant baculoviruses containing the HCMV IE cDNAs using site-specific transposition The first step toward isolating a viral mutant that lacks an essential gene is to generate a complementing cell line that provides all the functions of this gene product. This approach has been successfully used to generate several mutant herpesviruses, including an HCMV ie1 mutant (Greaves and Mocarski, 1998; Mocarski et al., 1996) . However, in the case of a promiscuous transactivator similar to IE2 86, whose overexpression in the host cells has a possible deleterious effect, a different approach was necessary.
Recombinant baculoviruses were constructed for expression of HCMV IE genes in FFs (Fig. 1) . These baculoviruses have a cassette (referred to as CAG) that has a composite promoter containing the CMV IE enhancer and chicken ␤-actin promoter and a rabbit ␤-globin polyadenylation signal (Niwa et al., 1991) . The vectors pFastBacI/CAG-IE72 and pFastBacI/CAG-IE86 (Figs. 1a and 1b) have the IE1 72 and IE2 86 cDNAs, respectively, placed in the CAG cassette downstream of the CA promoter and retain the insect polyhedrin promoter upstream of the CA promoter. The construct pFastBacI/IE86 (Fig. 1c) has the IE2 86 cDNA placed under the control of the insect polyhedrin promoter to generate recombinant baculoviruses expressing the IE2 86 gene product in insect cells. Finally, pFastBacI/IE1-2 (Fig. 1d) contains the UL122-123 region of HCMV cloned downstream of the CA promoter. Recombinant baculoviruses were generated via site-specific transposition as described under Materials and Methods. Since our aim was to generate recombinant baculoviruses that expressed the IE genes in human cells but not in insect cells, we first analyzed lysates of Sf9 cells infected with the recombinant baculoviruses derived from pFastBacI/CAG-IE1-2, pFastBacI/CAG-IE86, and pFastBacI/CAG-IE72 (BacCAG-IE1-2, Bac CAG-IE86, and Bac CAG-IE72, respectively) that contain the IE genes under the control of the CA promoter but with an intact polyhedrin promoter located further upstream. By Western blot analysis with an antibody that recognizes both IE proteins, we found that none of these viruses expressed IE2 86 (Fig. 2a, lanes 1, 2; Fig. 2b , lanes 5, 6) or IE1 72 (Fig. 2a, lanes 1, 2; Fig. 2c , lanes 3, 4) in Sf9 cells. As a control, we show that high levels of recombinant IE2 86 protein were present in Sf9 lysates infected with baculoviruses generated from the vector pFastBacI/IE86 (Bac IE86) that contains only the polyhedrin promoter (Fig. 2d,  lanes 2, 3, 4) . Bac CAG-IE86, and Bac CAG-IE72. FFs infected with Bac CAG-IE1-2 expressed IE2 86 but not IE1 72, as determined using the CH16.0 antibody (Fig. 2a, lanes 3, 4) . IE1 72 was not detected using an antibody that specifically detects this protein (data not shown), further confirming that the protein expressed is IE2 86. The reason that IE1 72 is not expressed from this vector could perhaps be attributed to the presence of the downstream ␤-globin polyadenylation signal. Both FFs and HeLa cells infected with Bac CAG-IE86 expressed recombinant IE2 86 (Fig.  2b, lanes 1-4) . Similarly, recombinant IE1 72 was expressed by FFs infected with Bac CAG-IE72 (Fig. 2c,  lanes 1, 2) . For comparison, we show the level of expression of IE1 72 in the ihfie 1.3 cells, which express the protein constitutively from an integrated retroviral vector (Fig. 2c, lane 6 ). As expected, no IE1 72 protein could be detected in uninfected FFs (Fig. 2c , lane 5).
To use baculoviruses as a complementing system, it was important to further analyze the levels of recombinant HCMV IE proteins expressed in FFs relative to that seen in HCMV infected cells. Figure Baculovirus-mediated expression of the HCMV IE proteins in FFs was also examined by immunofluorescence. High levels of IE1 72 and IE2 86 were detected in the nuclei of baculovirus infected cells by 24 h.p.i. (Figs. 3a and 3c, respectively). As controls, cells infected with HCMV ( Fig. 3e ) and uninfected cells (Fig. 3g ) are shown. Nuclei were visualized by Hoechst staining (Figs. 3b, 3d, 3f, and 3h). When cells were infected with the recombinant baculovirus at an m.o.i. of 100-200, expression of the IE proteins could be detected in 60-80% of the cells, with the percentage of IE1 72 expressing cells being slightly higher than those expressing IE2 86. In the course of these studies, we found that it was important that the cells be infected at a low density as the efficiency of the infection decreased when the cells approached confluence prior to infection. Therefore in all experiments the cells were less than 50% confluent when infected with baculovirus. As detected by immunofluorescence assays, the expression of IE2 86 from Bac CAG-IE86 persisted for at least 10 days postinfection (data not shown). One effect that we noted when the cells were infected at a high m.o.i. (200-400) is that the cells grew more slowly. In addition, some CPE was noted when the media was not changed daily.
The recombinant IE2 86 transactivates the HCMV UL112-113 promoter
The functionality of the IE2 86 expressed by the baculovirus was analyzed by testing its ability to transactivate the HCMV UL112-113 early promoter. This was done by using the recombinant Towne HCMV v148 CAT (Rodems et al., 1998) , which has the CAT gene cloned downstream of the UL112-113 promoter in the context of the US 9-10 region. FFs were either mock infected or infected with an empty recombinant baculovirus or a baculovirus expressing the HCMV IE proteins. After allowing 24 h for the accumulation of the IE gene products, cells were infected with HCMV v148 CAT in the presence of cycloheximide (CHX). The effect of the baculovirusexpressed IE proteins on the UL112-113 promoter was analyzed by studying the levels of the CAT transcripts. CHX was used to block the effects of the IE1 72 and IE2 86 expressed from HCMV v148 CAT. Northern blots of the RNA samples were probed with 32 P-labeled CAT cDNA. The levels of GAPDH mRNA in each lane were used as a reference for the total amount of RNA in each sample.
The CHX treatment completely blocked translation from the HCMV v148 CAT genome, as no CAT transcripts were observed in the absence of preinfection with baculovirus (Fig. 4, lane 2) . FFs that were preinfected with Bac CAG IE86 (lane 5) expressed 18-fold higher levels of CAT transcripts as compared to cells preinfected with a control baculovirus, Bac CAG (lane 3). Similarly, those preinfected with Bac CAG-IE1-2 contained 36-fold higher CAT mRNA (lane 6) over background levels. The effect of Bac CAG-IE72 on the early promoter was less dramatic (lane 4) and resulted in a fivefold upregulation. As expected, no CAT mRNA was detected in uninfected cells (lane 1). This experiment proved that the HCMV IE proteins produced from a recombinant baculoviral infection are functional and could potentially be used for complementation of IE mutants.
Bac CAG-IE72 efficiently complements HCMV ie1 mutants
The use of recombinant baculoviruses as a complementation system to support the growth of HCMV mutants was further analyzed by testing the replication of the previously characterized ie1 mutant CR208 (Greaves and Mocarski, 1998) in FFs infected with Bac CAG-IE72. This ie1 mutant exhibits a normal pattern of replication in primary human fibroblasts in high multiplicity infections, although no IE1 72 protein is present (Greaves and Mocarski, 1998) . However, when FFs are infected at low multiplicity, the virus is severely growth-restricted.
In the initial experiment, titers of CR208 were determined in FFs and ihfie 1.3 cells that were first infected with increasing m.o.i. of Bac CAG-IE72 and incubated for 48 h at 37°C to allow expression of the IE1 gene product. Bac CAG-IE72-infected and uninfected cells were then infected with 10-fold serial dilutions of CR208. A comparison of the resultant viral titers is represented in Table 1 . FFs that were not preinfected with Bac CAG-IE72 before the CR208 infection showed approximately a 100-fold decrease in the number of plaques on the FFs, as compared to the ihfie 1.3 cells. Upon infection with Bac CAG-IE72, however, the number of plaques increased in proportion to the m.o.i.
Optimal complementation was seen when the baculoviral infection was at an m.o.i. of 200. A further doubling of the amount of Bac CAG-IE72 resulted in a decrease in the number of CR208 plaques (data not shown). Examination of the data obtained with the ihfie 1.3 cells indicated that there was also a gradual decrease in CR208 titers with increasing m.o.i. of the recombinant baculovirus. Similar experiments with wild-type HCMV also resulted in a small decrease in viral titers on FFs and ihfie 1.3 cells as the m.o.i. of Bac CAG-IE72 increased, but in this case the decrease was first seen when a lower m.o.i. of Bac CAG-IE72 was used (data not shown). Taken together, these results suggest that the HCMV infection may be inhibited somewhat when the amount of the IE protein or the number of baculovirus genomes in the cells exceeds a certain threshold.
One concern with these types of experiments is that a dual infection with baculovirus expressing the wild-type IE protein and the HCMV mutant virus might lead to the generation of wild-type HCMV. To verify that Bac CAG-IE72 and CR208 coinfection did not lead to regeneration of IE1-positive HCMV, a total of 18 plaques from the complementation assay were further tested for their ability to form plaques on FFs and ihfie 1.3 cells. Individual plaques were resuspended in complete media and serially diluted for parallel infection of FFs and ihfie 1.3 cells. As shown in a representative experiment in Table  2 , the plaques from either Bac CAG-IE72 complementation or the ihfie 1.3 cells resulted in higher titers on ihfie 1.3 cells, as compared to primary fibroblasts. This assay was also extended to include Sf9 cells to determine whether the recombinant baculoviruses could replicate in FFs. However, no plaques were visualized on the insect cells confirming that these baculoviruses were indeed replication defective in primary fibroblasts (data not shown). This concurs with an earlier report that although the activity of a reporter gene was observed up to 14 days p.i., there was no detectable infectious bacu- lovirus in mammalian cells after 9 days p.i. (Shoji et al., 1997) .
DISCUSSION
The role of HCMV IE proteins IE1 72 and IE2 86 in the regulation of gene expression has been studied with great interest by several investigators (for review see Fortunato and Spector, 1999; Mocarski, 1996) . It is now evident that both IE1 72 and IE2 86 play key roles in influencing the transcriptional machinery of the host cell, as well as that of the virus. The activities of these proteins are achieved by interaction with cellular factors, as well as DNA binding in the case of IE2 86. Specifically, IE1 72 can bind several transcription factors, as well as the Rb-related protein, p107. It can also localize to PML (promyelocytic leukemia protein)-containing nuclear bodies (ND10 sites), thereby promoting the dispersal of PML. This phenomenon has been hypothesized to be the means by which HCMV utilizes the host cell's nuclear architecture for expression of viral gene products (Ahn and Hayward, 1997; Ishov et al., 1997; Kelly et al., 1995; see Fortunato and Spector, 1999 for review).
Our lab and others have primarily used transient expression systems and in vitro binding assays to delineate the functional domains of IE2 86 (reviewed in Fortunato and Spector, 1999) . In this way, it was found that the terminal 290-579 aa are responsible for autoregulation and DNA binding to its own promoter, as well as to some viral early promoters. In addition, the homodimerization of IE2 86 and its binding to other cellular proteins all appear to map to the region of the protein bounded by aa 86-542. The mapping of the activation domains of IE2 86 has been more problematic as the results depend on the target promoter used as well as the host cells. Work from our lab has focused primarily on the domains required for the activation of the HCMV early UL112-113 promoter and the 1.2-kb promoter in cells permissive for viral replication (Scully et al., 1995; Sommer et al., 1994) . These studies revealed that sequences between aa 26-85 and aa 290-579 are required for activation of both promoters. Stimulation of the 1.2-kb promoter also requires aa 86-135.
Although studies carried out so far have revealed a great deal of information about the functions of the IE proteins, the physiological significance of these putative functions can only be determined in the context of the viral infection by studying replication of viruses containing mutations in these genes. We and others have used a gene replacement strategy to construct recombinant HCMV by replacing a dispensable portion of the unique short region between the US9 and US10 genes with the promoter-reporter cassette of interest (Kohler et al., 1994; Rodems et al., 1998) . However, construction of HCMV lacking the IE genes has been more challenging. The isolation of the two ie1 mutants RC303⌬Acc and CR208 using a complementing fibroblast cell line helped elucidate the role of IE1 72 protein in the context of the infection (Greaves and Mocarski, 1998; Mocarski et al., 1996) . During a low m.o.i. infection, these mutants were severely replication defective. Interestingly, the presence of IE2 86 at wild-type levels during low m.o.i. infections did not compensate for the lack of IE1 72. This was directly reflected in the expression pattern of UL44 (a processivity factor for the HCMV DNA polymerase), which was lacking in low m.o.i. infections. Based on these data, it has been suggested that IE1 72 is responsible for transactivating this early gene, which is required to establish successful viral replication. Although IE1 72 is a key factor that promotes early infection events, it is not completely essential because high m.o.i. infections of the ie1 mutant viruses proceed with wild-type kinetics.
Since one of the major interests in our laboratory has been the study of gene regulation mediated by IE2 86, we have tried several different strategies to establish cell lines that could express the IE2 86 protein. We have also used viral vectors such as replication-defective adenoviruses and retroviruses to express HCMV IE proteins. Although we have successfully constructed adenoviruses that express high levels of IE1 72 (R. S. Dwarakanath and D. H. Spector, unpublished results), IE2 86 recombinants could not be isolated. In this paper, we describe an approach using recombinant baculoviruses whereby constitutive expression of the HCMV IE1 72 and IE2 86 proteins can be achieved in primary fibroblasts.
In isolating Bac CAG-IE72 and Bac CAG-IE86, the baculovirus shuttle vector and bacmid technology was utilized (Luckow et al., 1993) . The recombinant bacmids that were generated by site-specific transposition in bacteria were infectious when introduced into Sf9 cells, leading to the generation of pure stocks of recombinant viruses. The relative ease with which Bac-CAG-IE86 was constructed is likely due to the fact that the CA promoter in the virus does not lead to the expression of any wild-type IE2 86 in the Sf9 cells used for propagating the recombinant baculovirus. Several different bacmid clones have been successfully used for the generation of each recombinant virus. Two major criteria seemed to influence IE expression in FFs: first, the m.o.i. at which the baculoviruses were used; and second, the confluent state of the cells. A careful optimization of both these factors revealed that when FFs were plated so that they were less than 50% confluent, greater than 60-70% of the cells expressed the foreign proteins. The level of IE protein expression under such conditions is comparable to that of a wild-type HCMV infection, where all the cells in culture express the IE proteins. In our laboratory, the UL112-113 promoter has been routinely used to study the functionality of the IE2 86 protein (Klucher et al., 1993; Rodems et al., 1998; Schwartz et al., 1996; Sommer et al., 1994; Staprans et al., 1988) . The recombinant virus HCMV v148 CAT (Rodems et al., 1998) was therefore used to demonstrate high levels of transactivation of the early promoter by the recombinant IE proteins generated from recombinant baculoviruses. Higher levels of transactivation were observed when IE2 86 was expressed from the genomic fragment than from the cDNA. This may be due to the fact that the genomic fragment is from strain AD169, while the origin of the cDNA is the Towne strain of HCMV.
In view of the advantages discussed here, recombinant baculoviruses could be used for the in vivo analysis of individual HCMV proteins. In support of this argument, we have recently reported the use of Bac CAG-IE72 and Bac CAG-IE86 to analyze the effect of HCMV IE expression on HCMV-mediated cyclin E induction (McElroy et al., 2000) . Specifically, we demonstrated that these IE proteins were not sufficient for the upregulation of cyclin E levels that is observed during HCMV infection.
The complementation assays carried out with Bac CAG-IE72 document the applicability of the recombinant baculovirus technology for propagating mutant HCMV. We have addressed several issues in the design of these assays. First, the use of Bac CAG-IE72 in FFs resulted in CR208 titers comparable to the IE1 expressing cell line, ihfie 1.3. Increasing amounts of IE1 72 in FFs provided by Bac CAG-IE72 caused a corresponding increase in the number of CR208 plaques. However, above a certain m.o.i., a decrease in viral replication was observed. The presence of very high amounts of Bac CAG-IE72 inhibited plaque formation of CR208 as well as HCMV Towne in both cell types. This effect could be caused by the elevated levels of IE1 72 protein or possibly by a synergistic antiviral effect due to the elevated levels of interferon-␣ and -␤ that may be generated in baculovirus infected cells (Gronowski et al., 1999) . Second, Bac CAG-IE72 complementation did not result in any undesired recombination events that could generate wild-type HCMV from CR208.
One of the recent advancements in herpesvirus biology has been the cloning of the HCMV genome as an infectious bacterial artificial chromosome (BAC) and the use of site-directed, transposon-mediated mutagenesis to produce HCMV mutants in this system (Borst et al., 1999; Brune et al., 1999; Delecluse et al., 1998; Messerle et al., 1997; Wagner et al., 1999) . This technology, coupled with bacmid-mediated generation of recombinant baculoviruses, now provides a new strategy for efficiently isolating viruses with mutations in essential genes. (Greaves and Mocarski, 1998; Mocarski et al., 1996) were provided by Dr. Edward Mocarski (Stanford University) and grown in the media described above that was also supplemented with 400 g of geneticin (GIBCO-BRL) per milliliter. HCMV Towne strain was obtained from American Type Culture Collection (VR 977) and propagated as previously described (Tamashiro et al., 1982) . The ie1 deletion mutant CR208 (Greaves and Mocarski, 1998 ) was a generous gift from Dr. Edward Mocarski. Unless otherwise noted, ihfie 1.3 cells were used for the propagation of these mutant viruses and determination of their titers by plaque assay.
MATERIALS AND METHODS

Cells and viruses
Suspension cultures of
Molecular cloning
The pAdex1CAwt cosmid (Miyake et al., 1996) was a generous gift from Dr. Yumi Kanegae. The 2.3-kb IE2 86 cDNA was excised from pSGIE86 (Klucher et al., 1993) with BamHI, end repaired with Klenow enzyme, and subcloned into the SwaI site of the cosmid vector pAdex1Cawt yielding pAdex/IE86. In this construct, the IE2 86 cDNA is placed downstream of the chicken actin promoter and upstream of the rabbit ␤-globin polyadenylation signal. The CAG-IE86 cassette was then excised from pAdex/IE86 with PmeI, EcoRI linkers (Stratagene) were added to the blunt ends, and this fragment was ligated into the EcoRI site of baculovirus transfer vector pFastBac1 (GIBCO-BRL) to give pFastBacI/CAG-IE86.
A control vector for the expression of IE2 86 in Sf9 cells, pFastBacI/IE86, was derived by subcloning the BamHI fragment of the IE2 86 cDNA from pSGIE86 into the BamHI site of pFastBac1.
The construct pFastBacI/CAG-IE72 was derived using an alternate strategy. The CAG cassette was excised from pAdex1CAwt by PmeI digestion and then ligated into the StuI site of pFastBac1 to yield pFastBacI/CAG. The orientation of the CAG fragment in this construct was verified by restriction analysis. The IE1 72 cDNA fragment was excised from pSGIE72 (Klucher et al., 1993) by BamHI digestion, end repaired with Klenow enzyme, and ligated into the SwaI site of pFastBacI/CAG to give pFastBacI/CAG-IE72. The orientation of the IE1 72 cDNA with reference to the CAG cassette was further confirmed by restriction analysis.
The vector pFastBacI/CAG-IE1-2 was constructed to express wild-type IE2 86 from the genomic fragment of the UL122-123 region. This was done by subcloning the EcoRI fragment of the genomic DNA from pSGIE1-2 (Klucher et al., 1993) into the SwaI site of pFastBacI/CAG.
Recombinant bacmid preparation
The BAC-TO-BAC system was purchased from GIBCO-BRL. In this system, recombinant baculoviruses are generated by Tn7-mediated site-specific transposition of the expression cassette into a baculovirus expression vector. The baculoviral genome is maintained as a bacmid, a low-copy-number episome in E. coli DH10 Bac cells. The bacmid contains a kanamycin-resistance marker and a lacZ gene, so that transposition can be monitored by blue-white color selection. Transposition events disrupt the lacZ coding sequence, resulting in white colonies. DH10 Bac cells containing wild-type bacmids were transformed with vectors pFastBacI/CAG-IE1-2, pFastBacI/CAG-IE86, pFastBacI/IE86, or pFastBacI/CAG-IE72. The resultant white colonies were used for isolation of recombinant bacmid DNA. The presence of the high molecular weight (Ͼ135 kb) bacmid DNA was confirmed by agarose gel electrophoresis before the bacmids were used for transfecting Sf9 cells.
Recombinant baculovirus amplification and titering
Recombinant bacmids were introduced into Sf9 cells using CellFECTIN (GIBCO-BRL). Briefly, 9 ϫ 10 5 log phase cells were seeded onto 35-mm tissue culture plates and allowed to attach for at least 1 h. Cells were washed in serum-free media before the DNA-lipid complexes were overlaid onto the cells. After a 5 h incubation at room temperature, the cells were washed and incubated with fresh media. The recombinant baculovirus was harvested from the cell culture medium at 72 h posttransfection. The culture supernatants were clarified by centrifugation and virus stocks were stored in the dark at 4°C. Amplification of viral stocks was carried out by infecting Sf9 monolayers at a m.o.i. of 0.1-1.0. Culture supernatants were harvested 4-6 days postinfection, and the titers of recombinant baculoviruses were determined by plaque assay on Sf9 monolayers (Rodems and Friesen, 1993) .
Infection of FFs with recombinant baculoviruses
FFs were seeded onto tissue culture dishes to 50% confluence and allowed to attach at 37°C for 2 h. The culture media was aspirated and the viral inoculum (Sf9 culture supernatants made up to the required volume with complete DMEM) overlaid in a volume of 0.2-0.5 ml. Infection was carried out at room temperature for 1 h. The inoculum was removed completely and replaced with fresh media. Cells were incubated at 37°C and harvested at the indicated times for Western blot and immunofluorescence analyses.
Western blot analysis
Cell pellets were resuspended in PBS and the cells were lysed by five freeze/thaw cycles. Protein content in samples was determined with the BioRad reagent before boiling with reducing Laemmli buffer (2% SDS, 10% glycerol, 100 mM DTT, 60 mM Tris, pH 6.8, 2 g/ml of aprotinin and leupeptin, 1mM PMSF, 50 mM NaF, 0.5 mM Na 3 VO 4 , 4 mM EDTA, 10 mM Na 2 P 2 O 7 , 1 mM benzamidine, and 1 mM Na 2 S 2 O 5 ). Samples were then electrophoresed on 10% SDS-polyacrylamide gels and transferred onto an Immobilon P (Millipore) membrane. Filters were probed with a mouse monoclonal antibody, CH16.0 (Goodwin Institute), which is specific for HCMV IE1 72 and IE2 86, at a dilution of 1:20,000. The HRP-linked secondary anti-mouse IgG antibody (1:5000, Calbiochem) was detected using chemiluminescent methods (Supersignal, Pierce).
Immunofluorescence of infected FFs
Cells were grown on coverslips and infected with the recombinant baculoviruses as described above. Coverslips were washed twice with PBS, simultaneously fixed and permeabilized in cold methanol for 10 min at Ϫ20°C, and then rinsed three times with PBS. The HCMV IE proteins were detected using the CH16.0 antibody as previously described (McElroy et al., 2000) . Slides were viewed under a Zeiss fluorescence microscope and the images were captured with an MTT CCD2 camera using NIH image software. Images were then processed using Adobe Photoshop 3.0 and Adobe Illustrator 8.0.
RNA analysis
FFs infected with either Bac CAG-IE72, Bac CAG-IE86, or Bac CAG-IE1-2 were allowed to express the recombinant IE protein. At 24 h.p.i., they were treated with cycloheximide at a concentration of 100 g/ml for 3 h. The cells were then washed and infected in the presence of CHX with a recombinant HCMV Towne that expresses the chloramphenicol acetyl transferase (CAT) gene product under the control of the UL112-113 early promoter (v148CAT, Rodems et al., 1998) . At 7 h post-v148CAT infection, cells were harvested by trypsinization and total RNA was isolated using the Trizol reagent (Life Technologies). Twenty micrograms of each sample was electrophoresed on a denaturing formaldehyde agarose gel according to standard protocols. The gel was transferred to a nylon membrane and the RNA hybridized to DNA probes labeled with 32 P using Prime-It II (Stratagene). Phosphorimager (Molecular Dynamics) analysis was performed to quantify the strength of the signal.
Complementation assays
FFs or ihfie 1.3 (a total of 10 6 cells/dish) were seeded onto separate 24-well dishes and allowed to settle for 2 h at 37°C. Cultures were either mock infected with Sf9 culture supernatants or infected with the recombinant baculovirus expressing IE1 72 as described above. Plaque assays were then carried out on these cells 24-48 h.p.i. with the recombinant baculovirus. Tenfold serial dilutions of either HCMV Towne or the ie1 mutant viruses were assayed. The viral inoculum was aspirated after 24 h, and the cells were overlaid with 0.5% agarose in MEM Earle's media. Viral plaques were counted between 9-11 days after infection and titers calculated. Results shown are mean values derived from two to three independent experiments.
